GlassScriptPhysician profile
Vicki Matthews
NPI 1891373528
$4,081.63
in general payments reported to CMS, 2019-2025
13 companies · $1,385 in 2025
The $1,385 reported for 2025 was more than what 87% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $152 · 2022: $945 · 2023: $774 · 2024: $825 · 2025: $1,385.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,984.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,984.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $982.88 | 2021-2025 | Pifeltro, Delstrigo, Capvaxive |
| Theratechnologies INC. | $811.27 | 2021-2025 | Egrifta, Trogarzo |
| Abbvie INC. | $790.75 | 2022-2025 | |
| Viiv Healthcare Company | $731.71 | 2022-2025 | Rukobia, Dovato, Apretude |
| Axsome Therapeutics, INC. | $226.15 | 2023-2025 | Auvelity |
| Janssen Biotech, INC. | $188.83 | 2021-2023 | Symtuza |
| Alkermes, INC. | $117.30 | 2022 | |
| Napo Pharmaceuticals INC | $100.60 | 2024-2025 | Mytesi |
| Exact Sciences Corporation | $63.71 | 2024-2025 | Cologuard Collection Kit |
| Csl Behring | $21.77 | 2024 | Hizentra |
| Teva Pharmaceuticals USA, INC. | $19.65 | 2024 | Uzedy |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.53 | 2022 | |
| Emd Serono, INC. | $13.48 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vicki Matthews listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.